Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DEFERASIROX, with a corresponding US DMF Number 24209.
Remarkably, this DMF maintains an Active status since its submission on October 28, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2016, and payment made on February 18, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II